Providence First Trust’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$563K Buy
+1,455
New +$540K 0.16% 141
2025
Q4
Sell
-753
Closed -$243K 176
2025
Q3
$243K Hold
753
0.08% 103
2025
Q2
$293K Hold
753
0.1% 98
2025
Q1
$328K Hold
753
0.13% 90
2024
Q4
$278K Hold
753
0.1% 94
2024
Q3
$392K Buy
+753
New +$402K 0.17% 73
2023
Q2
Sell
-517
Closed -$238K 91
2023
Q1
$238K Hold
517
0.14% 83
2022
Q4
$265K Buy
+517
New +$263K 0.16% 85

Other funds holding ELV

Providence First Trust's ELV Position: Q2 2026 in Review

Providence First Trust opened a new position in Elevance Health (ELV) in Q2 2026: 1,455 shares worth $563K. The stake represents 0.16% of the portfolio and ranks #141 among its holdings. This is a return to the name: Providence First Trust previously reported a position in ELV as recently as Q3 2025.

Providence First Trust first reported a position in ELV in Q4 2022 and has held it in 8 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Providence First Trust held 1,455 shares of Elevance Health worth $563K as of Q2 2026.
  • Elevance Health was a new Providence First Trust position in Q2 2026.
  • Elevance Health made up 0.16% of Providence First Trust's portfolio in Q2 2026, its #141 holding.
  • Providence First Trust first reported a position in Elevance Health in Q4 2022 and has held it in 8 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Providence First Trust's 13F filing for Q2 2026, filed 27 Jul 2026.